Recent news on Vivelle

Noven Announces 2007 Annual Meeting Results  -  May 18, 2007
Genetic Engineering News (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(R) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Noven to Present at Deutsche Bank Annual Health Care Conference  -  Apr 25, 2007
PharmaLive.com (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(R) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Noven to Present at Deutsche Bank Annual Health Care Conference  -  Apr 25, 2007
Genetic Engineering News (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(R) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Noven to Present at Deutsche Bank Annual Health Care Conference  -  Apr 25, 2007
Business Wire (press release),Noven’s prescription patches are approved in over 30 countries and include Vivelle-Dot ® (the most prescribed estrogen patch in the US) and Daytrana™ (the

Noven Announces First Quarter 2007 Earnings Release Date  -  Apr 23, 2007
PharmaLive.com (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(R) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Noven Announces 2006 Financial Results  -  Mar 2, 2007
PharmaLive.com (press release),Thanks to growth in our Vivelle-Dot(R) estrogen patch and an outstanding effort by our sales force, the Novogyne joint venture had a record year.

Noven to Present at Lehman Brothers Global Healthcare Conference  -  Mar 14, 2007
PharmaLive.com (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(R) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Study: Menopause hormone patch may be safer  -  Mar 6, 2007
Wilkes Barre Times-Leader,Barbara Isaac, a research nurse and women’s health study coordinator at Albert Einstein College of Medicine, switched to Vivelle, sold by Novogyne

Hormones seen less risky in patch or gel  -  Feb 27, 2007
Newsday,The most popular brands include Climara, made by Berlex of Wayne, NJ, and Vivelle-Dot from Novogyne, a joint venture of Novartis and Noven Pharmaceuticals.

French Study Finds Skin Patches Might Lower Risk of Hormone Use  -  Feb 26, 2007
International News Service,Barbara Isaac, a research nurse and women's health study coordinator at Albert Einstein College of Medicine, switched to Vivelle, sold by Novogyne

Hormone replacement patch safer than pills: study  -  Feb 26, 2007
CBC News,Barbara Isaac, a research nurse and women's health study co-ordinator at Albert Einstein College of Medicine, switched to Vivelle, sold by Novogyne

Study: Hormone patch safer than pill  -  Feb 25, 2007
Hinesberg Journal,Barbara Isaac, a research nurse and women‘s health study coordinator at Albert Einstein College of Medicine, switched to Vivelle, sold by Novogyne

Hormone Patches Safer Than Pills in Treating Menopause  -  25 Feb 2007
FOX NewsBarbara Isaac, a research nurse and women's health study coordinator at Albert Einstein College of Medicine, switched to Vivelle, sold by Novogyne

Noven Announces 2006 Earnings Release Date and Upcoming Investor ...  -  Feb 23, 2007
PharmaLive.com (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(TM) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Noven to Present at Deutsche Bank Small Cap Growth Conference  -  Feb 7, 2007
PharmaLive.com (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(TM) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Hormone patch shows benefit over pill  -  Feb 21, 2007
Press-Enterprise (subscription),...tan or clear patches aren't widely used in the US The most popular brands include Climara, made by Berlex of Wayne, NJ, and Vivelle-Dot from Novogyne,

Risa Bernstein, Agency Co-Founder, Returns to Flashpoint Medica  -  Jan 17, 2007
PharmaLive.com (press release),Enzon for Abelcet, an IV anti-fungal agent, Novogyne (Noven and Novartis) for Vivelle Dot (estradiol transdermal system), a hormone replacement patch,

Noven Provides Update on Daytrana Methylphenidate Transdermal System  -  Nov 29, 2006
PharmaLive.com (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(TM) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Noven Reports Third Quarter 2006 Financial Results  Nov 6, 2006
...“Vivelle-Dot™, the most prescribed transdermal estrogen therapy in the US, had the highest quarterly prescriptions in its history and contributed to ... -Business Wire (press release), Noven Announces Third Quarter Earnings Release Date  Oct 26, 2006
Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(TM) (the most prescribed estrogen patch in the US) and Daytrana(TM) (the ... -PharmaLive.com (press release), MARKET INSIGHT: Noven Pharmaceuticals Poised for an Upside Move  Oct 19, 2006
Vivelle-Dot is a transdermal estrogen therapy product marketed primarily under the brand name Estradot outside the United States. ... -Inside Futures, Foro de Shell Security - Seguridad informática  Oct 27, 2006
This increased incidence may be related vivelle o environmental factors, such as increased exposure vivitrol o toxic chemicals, rather than to genetic factors ... -Shell Security, Noven Presents Pre-Clinical Study Data at AAPS Annual Meeting  Oct 30, 2006
Noven’s prescription patches are approved in over 30 countries and include Vivelle-Dot™ (the most prescribed estrogen patch in the US) and Daytrana™ (the ... -Business Wire (press release), Doctors Challenge Suzanne Somers' Anti-Aging Advice  Oct 22, 2006
This includes prescriptions for bioidentical estrogens such as Estrace, Vivelle-Dot, Climara, Estring, and Vagifem, as well as several generic forms, and ... -FOX News Noven to Present at UBS Global Life Sciences Conference  Sep 21, 2006
Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(TM) (the most prescribed estrogen patch in the US) and Daytrana(TM) (the ... -Genetic Engineering News

Bioidentical hormones lack long-term studies  Sep 15, 2006
...estrogen products include pills (eg, Estrace), vaginal creams (Estrace), skin patches (eg, Alora, Climara, Esclim, Estraderm, Vivelle), transdermal gel ... -Belleville News-Democrat

Noven Provides Update on Daytrana Methylphenidate Transdermal System  -  Nov 29, 2006
PharmaLive.com (press release),Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(TM) (the most prescribed estrogen patch in the US) and Daytrana(TM)

Recent Controversy over Suzanne Somers is a Disservice to Women ...  -  Nov 21, 2006
Emediawire (press release),But other bioidentical hormones are available in a number of doses from conventional pharmaceutical companies under names like Vivelle, Climara and

Noven Reports Second Quarter 2006 Financial Results; Quarter ...  Aug 9, 2006
...net revenues at Novogyne decreased 4% to $30.6million, reflecting increased sales returns allowances, partiallyoffset by increased sales of Vivelle-Dot(TM). ... -Finanzen.net

Noven Reports Second Quarter 2006 Financial Results; Quarter ...  Aug 9, 2006
...net revenues at Novogyne decreased 4% to $30.6 million, reflecting increased sales returns allowances, partially offset by increased sales of Vivelle-Dot(TM). ... -Business Wire

John Spetrino Named Chief Creative Officer at Flashpoint Medica  Aug 23, 2006
Genentech for Herceptin, a treatment for breast cancer; UCB for Tussionex, Integra Life Sciences for Mozaik, a spinal fusion product; Noven for Vivelle Dot, a ... -Yahoo! News

Noven Announces Second Quarter Earnings Release Date  Aug 1, 2006
Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(TM) (the most prescribed estrogen patch in the US) and Daytrana(TM) (the ... -PharmaLive.com

Noven Confirms Availability of Daytrana(TM) Methylphenidate ...  Jun 29, 2006
Noven's prescription patchesare approved in over 30 countries and include Vivelle-Dot(TM) (themost prescribed estrogen patch in the US) and Daytrana(TM ... -Finanzen.net

Noven Confirms Availability of Daytrana Methylphenidate ...  Jun 29, 2006
Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot(TM) (the most prescribed estrogen patch in the US) and Daytrana(TM) (the ... -PharmaLive.com



Noven Reports First Quarter 2006 Financial Results  May 1, 2006
Noven's net revenues for the current quarter were $10.2 million, a 13% decrease from the 2005 quarter, primarily due to the timing of Vivelle-Dot(TM) shipments ... - PharmaLive.com

Noven Reports First Quarter 2006 Financial Results  May 1, 2006
Noven believes that the increase in Vivelle-Dot(TM)sales was related to trade customers reducing their inventories in the2005 quarter and, to a lesser extent ... - Finanzen.net

Q1 earnings rise at Noven  May 1, 2006
...about $3 million. Noven said its revenue decline was primarily due to the timing of Vivelle-Dot shipments to Novogyne. The product ... - South Florida Business Journal

Noven sets aside $300K for lawsuits  May 2, 2006
Since the Women's Health Initiative raised questions in 2002 about the safety of hormonal treatment for menopausal women, sales of Noven's Vivelle-Dot patch ... - Miami Herald

Noven Pharmaceuticals 1Q Profit Rises  May 1, 2006
Revenue totaled $10.2 million versus $11.7 million a year earlier, down 13 percent due to the timing of shipments of its Vivelle-Dot estrogen patch to treat ... - MSN Money

Noven Pharma Q1 Profit Edges Despite Lower Revenue - Update  May 1, 2006
...quarter. Noven's net revenues of $10.2 million declined 13% from $11.7 million due to the timing of Vivelle-Dot shipments to Novogyne. ... - Trading Markets





Launch of an Innovative Way to Learn About Menopause: Customized ...  Apr 10, 2006
The website and newsletter are created by Novogyne Pharmaceuticals, the makers of Vivelle-Dot(TM) (estradiol transdermal system), the world's smallest estrogen ... - Yahoo! News

Noven Announces FDA Approval of Daytrana Methylphenidate ...  Apr 7, 2006
Among other products, Novogyne markets and sells Noven's Vivelle-Dot(TM) product - the smallest estrogen patch in the world, and the most prescribed ... - PharmaLive.com

Noven Announces FDA Approval of Daytrana(TM) Methylphenidate ...  Apr 6, 2006
Among other products, Novogyne markets andsells Noven's Vivelle-Dot(TM) product - the smallest estrogen patch inthe world, and the most prescribed transdermal ... - Finanzen.net



Noven Vivelle-Dot sales up 11 percent  Jan 24, 2006
...said Tuesday that 2005 sales of its Vivelle-Dot estrogen treatment rose 11 percent even though the US estrogen market declined. ... - BusinessWeek

Noven Vivelle-Dot Sales Up 11 Percent  Jan 24, 2006
...said Tuesday that 2005 sales of its Vivelle-Dot estrogen treatment rose 11 percent even though the US estrogen market declined. ... - MSN Money

Noven Provides Update on Vivelle-Dot(TM) Estrogen Patch  Jan 24, 2006
...(NASDAQ:NOVN) today provided an update on prescription growth and other matters related to its lead commercialized product, Vivelle-Dot(TM) (estradiol ... - Genetic Engineering News

Noven Provides Update on Vivelle-Dot(TM) Estrogen Patch  Jan 24, 2006
...(NASDAQ:NOVN) today providedan update on prescription growth and other matters related to its leadcommercialized product, Vivelle-Dot(TM) (estradiol ... - Finanzen.net

US warns of brand errors in imported drugs  Jan 12, 2006
...in the FDA warning are: Aldactone, Alphadine, Antagon, Calan, Cervidil, Cloderm, Diasorb, Dilacor, Flomax, Hexalen, Naqua, Norpramin, Rubex, Urex and Vivelle. ... - International Herald Tribune

Warning About Online Medication Orders  Jan 19, 2006
...reliever. Vivelle is the name of a drug prescribed for menopause and osteoporosis, but in Austria it is a birth control pill. World ... - CBS4Boston

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional